Search
Now showing items 1-10 of 23
The use of siRNA technology for the identification of differentially expressed genes in DMD: possible targets for gene thepray
لطفا صفحه دو از فایل پیوست ملاحظه شود
The use of siRNA technology for identification of differentially expressed genes in Duchenne Muscular Dystrophy: Possible targets for gene therapy
لطفا صفحه دو از فایل پیوست ملاحظه گردد
Commercialization of Gene Therapy Drugs
Gene therapeutic research has been considered a risk based approach and faced many challenges in the past, as many ethical issues arose particularly after the first death caused by gene therapy in 1999. However, the journey of this research...
Mesenchymal Stem Cell: A New Vehicle for Cancer Therapy
Introduction: Cancer remains the second cause of death in the world after coronary heart disease. Nowadays, most researchers have focused on specific cancer therapy, without adversely affecting other normal tissues. ...
Lentiviral mediated overexpression of Insulin like Growth Factor-1 in mouse myoblast
Insulin-like growth factor gene (IGF-1) is one of the most important growth factors that plays a key role in the proliferation and differentiation of muscle cells. IGF-1 is also a radial stimulant in muscle hypertrophy in ...
Bioethical Concepts of Gene Therapy
Gene therapy involves the insertion of genes into the cells or tissues of individuals suffering from diseases and genetic disorders. Gene therapy can be classified into two main types, germ line gene therapy and somatic gene therapy. Although gene...
Gene Therapy; Pros and Cons
. Genome of lentivirus vectors (LVs) is integrated into the host cell genome and they accommodate a fair amount of foreign DNA. LVs are much less suitable for in vivo gene therapies due to their large diameter. Adenoviral vectors (AdVs) can be produced...
Novel Approaches for Muscular Dystrophy Treatment
signal for expansion is required to obtain a therapeutic effect. Beside stem cells, other
therapeutic strategies such as gene therapy are being tested in patients and pre-clinical models. Since almost all types of
muscular dystrophies arise...
Designing a vector for specific expression of recombinant proteins in epidermal keratinocytes, Using human factor IX cDNA as a model for expression analysis
We have designed a keratinocyte-specific expression plasmid equipped with the K14-promoter by
inserting a 2240bp BglII/HindIII fragment, containing the upstream regulatory elements of the K14 gene, in a
digested ...
A Study of the Expression of Functional Human Coagulation Factor IX in Keratinocytes Using a Nonviral Vector Regulated by K14 Promoter
Ex vivo gene therapy requires a suitable bioreactor for production and delivery of
the gene products into a target tissue, and keratinocyte is suitable model in this regard
because of its potential for systemic release of proteins...